Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease.
Shimizu M, Suzuki K, Kato K, Jojima T, Iijima T, Murohisa T, Iijima M, Takekawa H, Usui I, Hiraishi H, Aso Y. Shimizu M, et al. Among authors: usui i. Diabetes Obes Metab. 2019 Feb;21(2):285-292. doi: 10.1111/dom.13520. Epub 2018 Oct 2. Diabetes Obes Metab. 2019. PMID: 30178600 Clinical Trial.
Macrophage-specific hypoxia-inducible factor-1α deletion suppresses the development of liver tumors in high-fat diet-fed obese and diabetic mice.
Takikawa A, Usui I, Fujisaka S, Tsuneyama K, Okabe K, Nakagawa T, Nawaz A, Kado T, Jojima T, Aso Y, Hayakawa Y, Yagi K, Tobe K. Takikawa A, et al. Among authors: usui i. J Diabetes Investig. 2019 Nov;10(6):1411-1418. doi: 10.1111/jdi.13047. Epub 2019 Apr 11. J Diabetes Investig. 2019. PMID: 30897274 Free PMC article.
The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma.
Jojima T, Wakamatsu S, Kase M, Iijima T, Maejima Y, Shimomura K, Kogai T, Tomaru T, Usui I, Aso Y. Jojima T, et al. Among authors: usui i. Int J Mol Sci. 2019 Oct 22;20(20):5237. doi: 10.3390/ijms20205237. Int J Mol Sci. 2019. PMID: 31652578 Free PMC article.
CD-1db/db mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis.
Mizunuma Y, Kanasaki K, Nitta K, Nakamura Y, Ishigaki Y, Takagaki Y, Kitada M, Li S, Liu H, Li J, Usui I, Aso Y, Koya D. Mizunuma Y, et al. Among authors: usui i. J Diabetes Investig. 2020 Nov;11(6):1470-1481. doi: 10.1111/jdi.13311. Epub 2020 Jul 3. J Diabetes Investig. 2020. PMID: 32472621 Free PMC article.
124 results